In comparison with HCs, the frequency of plasmablasts (CD19+CD27+CD20-CD38+) was dramatically increased in SLE patients, particularly in active SLE patients, but it was not noticeably different between inactive patients and HCs (Figure 3B). Here, CD19 is linked to systemic lupus erythematosus.